MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company crating novel therapies, and unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients.
Domain
moonlaketx.com
Country
SwitzerlandIndustry
BiotechnologyEmployees
11-50
Last Funding
$75.0M
Founded
2021
Tech Stack (4 technologies)
Frequently Asked Questions
What technologies does MoonLake Immunotherapeutics use?+
MoonLake Immunotherapeutics uses 4 technologies including Bootstrap, jsDelivr, reCAPTCHA.
What industry is MoonLake Immunotherapeutics in?+
MoonLake Immunotherapeutics operates in the Biotechnology industry.
Where is MoonLake Immunotherapeutics based?+
MoonLake Immunotherapeutics is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026